Scott Rocklage

Dr. Scott Rocklage, Ph.D. is the managing partner at 5AM Ventures since 2003. He was the Chief Executive Officer at EPIRUS Biopharmaceuticals, Inc. from May 6, 2016 to July 25th, 2016. He was Acting Chief Executive Officer since May 6, 2016 until May 11th, 2016.

Dr. Rocklage has a Ph.D. in chemistry from UC Berkeley and a Ph.D. in chemistry from MIT. He has done his research in the laboratory of Richard. R. Shrock, Noble Prize in chemistry 2005. He is a co-creator or creator of over 30 U.S. patents and has more than 100 peer-reviewed publications.

Dr. Rocklage has had 30 years experience with healthcare management. 5 am Ventures is in the company formation business and it simply means they are new, starting early. Read more: Scott Rocklage | LinkedIn and Idea Mensch | Scott Rocklage

He works with entrepreneurs to bring new ideas to life. These entrepreneurs are usually scientists, physicians, or business executives. New cancer treatment is fascinating to Dr. Rocklage because now the technology is available to target specific mutations or genotypes. He is most productive as an entrepreneur when he uses time management, calendaring, and prioritization.

As an entrepreneur, he mentions having had failures with hiring certain people as a manager. He values measured risk-taking, and moving on from mistakes such as hiring the wrong person as previously mentioned. Dr. Rocklage’s other companies he has worked for include being CEO of Cubist Pharmaceuticals.

He has been the President and CEO of Nycomed Salutar, and has held Research and Development positions at Salutar and Catalytica. He has served as board chairman of Relypsa and Novira, which was acquired by Johnson & Johnson.

He has helped develop three new drugs of the following: Omniscan, Teslascan, and Cubicin. He has entered six drug candidates into clinical trials.

As of April 5th, 2017 he is the managing partner at 5AM Ventures, which focuses on building life science companies that deliver returns on investment.

5 AM Ventures has scientific, medical, operational, legal and financial expertise as an early investor in new companies. 5 AM ventures offers input to operating plans, strategy and management team development issues which new companies have solved.

Learn more about Scott Rocklage:

Scott M. Rocklage, PhD